159. Xeroderma pigmentosum Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 11 / Drugs : 17 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 15
Xeroderma pigmentosum and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 159 | Xeroderma pigmentosum | - |
| 53 | Sjogren syndrome | 1.865 |
| 49 | Systemic lupus erythematosus | 1.832 |
| 96 | Crohn disease | 1.821 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.814 |
| 39 | Toxic epidermal necrolysis | 1.018 |